Results 101 to 110 of about 38,630,120 (154)

Biomedical Data Manifest: A lightweight data documentation mapping to increase transparency for AI/ML. [PDF]

Sci Data
Bottomly D, Suciu CG, Cordier B, Evans N, Poire A, Zheng C, ARTNet Consortium, Tyner JW, Hutson A, McWeeney SK.   +9 more
europepmc   +1 more source

Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma. [PDF]

Mol Cancer
Crawford KJ, Humphrey KS, Cortes E, Wang J, Kumarasamy V, Wan Y, Long MD, Feigin ME, Witkiewicz AK, Mann KM, Knudsen ES, Abel EV.   +11 more
europepmc   +1 more source

Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models. [PDF]

Mol Cancer Ther
Wu J, Wang J, O'Connor TN, Tzetzo SL, Gurova KV, Knudsen ES, Witkiewicz AK.   +6 more
europepmc   +1 more source

NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression. [PDF]

J Immunol
Giridharan T, Suzuki S, Khan ANH, Liu Q, Attwood K, Stokolosa A, Mahan S, Witkiewicz AK, Joseph J, Moysich K, Langermann S, Lovewell R, Flies D, Myint H, Odunsi K, Emmons TR, Yaffe MB, Zsiros E, Dey P, McGray AJR, Segal BH.   +20 more
europepmc   +1 more source

BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis. [PDF]

JCO Precis Oncol
Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, Bonnefoi H, Knudsen E, Im SA, DeMichele A, Van't Veer L, Kim SB, Bear H, McCarthy N, Rhiem K, Turner N, Witkiewicz A, Rojo F, Filipits M, Martin LA, Fasching PA, Schem C, Becker K, García-Sáenz JA, Kelly CM, Reimer T, Toi M, Rugo HS, Denkert C, Gnant M, Makris A, Liu Y, Valota O, Felder B, Weber K, Nekljudova V, Loibl S.   +37 more
europepmc   +1 more source

Perinatal Outcomes and Level of Labour Difficulty in Deliveries with Right and Left Foetal Position-A Preliminary Study. [PDF]

Healthcare (Basel)
Witkiewicz M, Baranowska B, Węgrzynowska M, Kiersnowska I, Karzel K, Bączek G, Sys D, Scholz A, Crowther S, Teliga-Czajkowska J, Tataj-Puzyna U.   +10 more
europepmc   +1 more source

Three-Layered Composite Scintillator Based on the Epitaxial Structures of YAG and LuAG Garnets Doped with Ce³⁺ and Sc³⁺ Impurities. [PDF]

Materials (Basel)
Witkiewicz-Łukaszek S, Gorbenko V, Zorenko T, Pejchal J, Mares JA, Kucerkova R, Beitlerova A, Nikl M, Sidletskiy O, Winiecki J, D'Ambrosio C, Zorenko Y.   +11 more
europepmc   +1 more source

Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle. [PDF]

Nat Commun
Kumarasamy V, Wang J, Roti M, Wan Y, Dommer AP, Rosenheck H, Putta S, Trub A, Bisi J, Strum J, Roberts P, Rubin SM, Frangou C, McLean K, Witkiewicz AK, Knudsen ES.   +15 more
europepmc   +1 more source

Witkiewicz, Agnieszka K

, 2016
Witkiewicz, Agnieszka K
core  

Real-World Experience among Elderly Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitor-Based Therapy. [PDF]

Cancers (Basel)
O'Connor TN, Schultz E, Wang J, O'Connor T, Levine E, Knudsen ES, Witkiewicz AK.   +6 more
europepmc   +1 more source